A Smartphone App on Medication Adherence

Last updated: June 6, 2023
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Overall Status: Active - Enrolling

Phase

N/A

Condition

N/A

Treatment

the MedAdhere app

Clinical Study ID

NCT05892120
KMURCT20200096
  • Ages 20-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This is an experimental study which aims to explore the effectiveness of a smartphone app for medication adherence (MedAdhere app) among schizophrenic patients for eight weeks.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • schizophrenia
  • aged 20 to 65 years
  • able to read traditional Chinese
  • owning a smartphone
  • currently admitted at a psychiatric day-care center

Exclusion

Exclusion Criteria:

  • Intellectually disabled or severe cognitive function impairment (Dementia)

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: the MedAdhere app
Phase:
Study Start date:
June 01, 2023
Estimated Completion Date:
December 31, 2023

Study Description

Schizophrenia is a mental disorder that causes severe functional disabilities and imposes a heavy economic burden. Poor medication adherence is one of the major causes of relapse of psychiatric symptoms in schizophrenic patients. This is an experimental study which aims to explore the effectiveness of a smartphone app for medication adherence (MedAdhere app) among schizophrenic patients for eight weeks.

Connect with a study center

  • Kaohsiung Medical University

    Kaohsiung, 80708
    Taiwan

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.